ACM
CUE icon

Aquatic Capital Management’s Cue Biopharma CUE Stock Holding History

Aquatic Capital Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13
Closed -$1K – 1451
2022
Q3 		$1K Sell
13
-224
-95% -$19.3K ﹤0.01% 1124
2022
Q2 		$18K Buy
237
+234
+7,800% +$27.4K 0.01% 858
2022
Q1 		$0 Sell
3
-87
-97% -$18.4K ﹤0.01% 1166
2021
Q4 		$31K Buy
+90
New +$34.8K 0.06% 455

Other funds holding CUE

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aquatic Capital Management's CUE Position: Q4 2022 in Review

Aquatic Capital Management sold out of Cue Biopharma (CUE) in Q4 2022, closing a stake of 13 shares — an estimated $1K sold.

Aquatic Capital Management first reported a position in CUE in Q4 2021 and held it in 4 quarters. The position peaked at $31K in Q4 2021. 61 funds tracked by Wall St. Rank hold CUE as of Q4 2022.

  • Aquatic Capital Management reported no remaining Cue Biopharma position as of Q4 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 13 Cue Biopharma shares in Q4 2022, an estimated $1K.
  • Aquatic Capital Management first reported a position in Cue Biopharma in Q4 2021 and held it in 4 quarters.
  • Aquatic Capital Management's Cue Biopharma position peaked at $31K in Q4 2021.
  • 61 funds tracked by Wall St. Rank held Cue Biopharma as of Q4 2022.

Based on Aquatic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.